Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 44751-44800 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05270096
International Leukemia Target Board
N/A
Recruiting
600 participants
Started: Dec 31, 2022 · Completed: Jun 1, 2032
2 conditions
1 sponsor
1 location
NCT05661786
Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase
N/A
Recruiting
4,500 participants
Started: Dec 31, 2022 · Completed: May 31, 2028
1 condition
1 sponsor
5 locations
NCT05659628
CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL
PHASE1
Recruiting
24 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
2 locations
NCT05631041
Effect of Silymarin in Metastatic Colorectal Cancer Patients
PHASE3
Recruiting
64 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05395195
Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
PHASE3
Recruiting
504 participants
Started: Dec 31, 2022 · Completed: Dec 1, 2026
3 conditions
1 sponsor
10 locations
NCT05652517
Univu-guided Vein of Marshall Ethanol Infusion (Marshall-Merge)
NA
Recruiting
100 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05666336
Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients
PHASE4
Recruiting
30 participants
Started: Dec 31, 2022 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT05594095
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
PHASE2
Recruiting
620 participants
Started: Dec 30, 2022 · Completed: Dec 1, 2026
5 conditions
16 sponsors
1 location
NCT05457699
Ablative Radiotherapy to Consolidate Maximal Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate)
PHASE2
Recruiting
80 participants
Started: Dec 30, 2022 · Completed: Jul 30, 2030
1 condition
1 sponsor
1 location
NCT05617872
Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound
NA
Recruiting
75 participants
Started: Dec 30, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05136027
TReAtment With CombinedExercise in Patients With Resistant Major Depression
NA
Recruiting
70 participants
Started: Dec 30, 2022 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT05562024
TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma
PHASE1
Recruiting
24 participants
Started: Dec 30, 2022 · Completed: Feb 18, 2039
1 condition
3 sponsors
2 locations
NCT05648968
A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia
PHASE3
Recruiting
90 participants
Started: Dec 30, 2022 · Completed: May 2, 2029
1 condition
1 sponsor
89 locations
NCT05616468
BGT007 Cell Treatment of Nasopharyngeal Carcinoma
EARLY_PHASE1
Recruiting
23 participants
Started: Dec 30, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05659186
PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer
PHASE2
Recruiting
20 participants
Started: Dec 30, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05646576
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
NA
Recruiting
90 participants
Started: Dec 30, 2022 · Completed: Apr 1, 2027
5 conditions
2 sponsors
1 location
NCT05672524
A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
PHASE2
Recruiting
37 participants
Started: Dec 30, 2022 · Completed: Dec 30, 2025
5 conditions
1 sponsor
7 locations
NCT05961787
A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE)
NA
Recruiting
134 participants
Started: Dec 30, 2022 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT05633732
Developing Echocardiography Image Quality Management System Based on Deep Learning
N/A
Recruiting
2,000 participants
Started: Dec 30, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05837806
Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC)
PHASE2
Recruiting
27 participants
Started: Dec 30, 2022 · Completed: Dec 30, 2027
1 condition
1 sponsor
1 location
NCT05703048
The Effect of Esmolol Versus Dexmedetomidine on Postoperative Pain Control in Endoscopic Sinus Surgery: A Randomized Trial
NA
Recruiting
70 participants
Started: Dec 30, 2022 · Completed: Jun 30, 2024
2 conditions
1 sponsor
1 location
NCT06332508
Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL)
PHASE1
Recruiting
36 participants
Started: Dec 30, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05406570
Personalized Tidal Volume in ARDS (VT4HEMOD)
NA
Recruiting
10 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06027892
Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer
NA
Recruiting
562 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2032
1 condition
1 sponsor
1 location
NCT05623722
Erector Spinae Plane Block Improves Organ Dysfunction in Septic Patients With Acute Gastrointestinal Injury
NA
Recruiting
116 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2026
3 conditions
3 sponsors
1 location
NCT05622409
A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma
N/A
Recruiting
250 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2030
1 condition
1 sponsor
8 locations
NCT05377307
Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
N/A
Recruiting
49 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2037
5 conditions
1 sponsor
5 locations
NCT05853198
Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability
NA
Recruiting
165 participants
Started: Dec 29, 2022 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT05024773
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
PHASE3
Recruiting
112 participants
Started: Dec 29, 2022 · Completed: Nov 30, 2027
1 condition
1 sponsor
47 locations
NCT06258408
A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors
PHASE1
Recruiting
78 participants
Started: Dec 29, 2022 · Completed: Jul 31, 2025
1 condition
1 sponsor
2 locations
NCT05673057
Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome
PHASE1/PHASE2
Recruiting
249 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2029
4 conditions
1 sponsor
9 locations
NCT05687851
Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer
PHASE2
Recruiting
33 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2026
1 condition
4 sponsors
1 location
NCT06273449
A Smart Digital Workflow Towards High Precision and Through-Put Production for Removable Partial Dentures
NA
Recruiting
141 participants
Started: Dec 29, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04552080
The Effect of Systemic Antibiotics on Post-surgical Complications and Patient-centered Outcomes in Patients Undergoing Implant Surgery With Guided Bone Regeneration and Simultaneous Sinus Floor Elevation
PHASE4
Recruiting
30 participants
Started: Dec 29, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05595642
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
PHASE3
Recruiting
1,290 participants
Started: Dec 29, 2022 · Completed: Mar 11, 2027
1 condition
1 sponsor
462 locations
NCT05587543
Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma
EARLY_PHASE1
Recruiting
24 participants
Started: Dec 28, 2022 · Completed: Oct 31, 2030
1 condition
1 sponsor
1 location
NCT05349370
Lactate Kinetics in Septic Shock
NA
Recruiting
60 participants
Started: Dec 28, 2022 · Completed: Dec 31, 2026
2 conditions
4 sponsors
1 location
NCT06175780
Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors
PHASE1
Recruiting
189 participants
Started: Dec 28, 2022 · Completed: Dec 28, 2025
2 conditions
1 sponsor
8 locations
NCT06142175
Relmacabtagene Autoleucel in Patients With LBCL
N/A
Recruiting
200 participants
Started: Dec 28, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05442515
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
PHASE1/PHASE2
Recruiting
126 participants
Started: Dec 28, 2022 · Completed: Jul 1, 2029
11 conditions
1 sponsor
1 location
NCT05464186
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
NA
Recruiting
200 participants
Started: Dec 28, 2022 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT05556603
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in PANCEATIC Cancer (ASCEND-PANCREATIC)
N/A
Recruiting
7,062 participants
Started: Dec 28, 2022 · Completed: Dec 31, 2029
1 condition
2 sponsors
3 locations
NCT05613413
A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients with Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC)
PHASE2
Recruiting
36 participants
Started: Dec 28, 2022 · Completed: Sep 30, 2028
1 condition
1 sponsor
1 location
NCT05568719
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
PHASE3
Recruiting
263 participants
Started: Dec 28, 2022 · Completed: Feb 25, 2040
2 conditions
1 sponsor
12 locations
NCT05464992
Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI
NA
Recruiting
800 participants
Started: Dec 28, 2022 · Completed: Dec 28, 2036
2 conditions
1 sponsor
1 location
NCT05466357
Application Research on Endoscopic Pseudocapsule-Based Resection for Pituitary Adenomas
NA
Recruiting
30 participants
Started: Dec 28, 2022 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT06404983
Opioid-free Anaesthesia in Breast Cancer Surgery
NA
Recruiting
200 participants
Started: Dec 28, 2022 · Completed: Sep 12, 2027
6 conditions
1 sponsor
1 location
NCT05526989
Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
PHASE2
Recruiting
25 participants
Started: Dec 28, 2022 · Completed: Nov 30, 2027
1 condition
2 sponsors
2 locations
NCT05700357
Different Local Anesthetic Volumes for TPVB in Post-thoracotomy Analgesia
NA
Recruiting
75 participants
Started: Dec 28, 2022 · Completed: Dec 28, 2024
5 conditions
1 sponsor
1 location
NCT04920708
Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression
PHASE2
Recruiting
324 participants
Started: Dec 28, 2022 · Completed: Sep 30, 2026
3 conditions
3 sponsors
18 locations
Previous
1
More pages
893
894
895
896
897
898
899
More pages
1333
Next